{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:32:22Z","timestamp":1740123142556,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-10048-z","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T14:02:42Z","timestamp":1730124162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of the viral genome of Omicron variants of SARS-CoV-2 circulating in Tripura, a remote frontier state in Northeastern India"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-9606","authenticated-orcid":false,"given":"Ankan","family":"Chakrabarti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-8070","authenticated-orcid":false,"given":"Saikat","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-8241","authenticated-orcid":false,"given":"Apurba","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-133X","authenticated-orcid":false,"given":"Tapan","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"10048_CR1","unstructured":"World Health Organization (WHO) (2021) Listings of WHO\u2019s response to COVID-19. (accessed 4 February 2023), https:\/\/www.who.int\/news\/item\/29-06-2020-covidtimeline"},{"key":"10048_CR2","doi-asserted-by":"crossref","unstructured":"Rana R, Kant R, Huirem RS, Bohra D, Ganguly NK (2022) Omicron variant: Current insights and future directions. Microbiol Res;265:127204. https:\/\/doi.org\/10.1016\/j.micres.2022.127204","DOI":"10.1016\/j.micres.2022.127204"},{"issue":"1","key":"10048_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-022-03094-y","volume":"80","author":"S Chakraborti","year":"2022","unstructured":"Chakraborti S, Gill J, Goswami R, Kumar S, Chandele A, Sharma A (2022) Structural profiles of SARS-CoV-2 variants in India. Curr Microbiol 80(1):1. https:\/\/doi.org\/10.1007\/s00284-022-03094-y","journal-title":"Curr Microbiol"},{"key":"10048_CR4","doi-asserted-by":"publisher","unstructured":"Kim S, Liu Y, Ziarnik M, Cao Y, Zhang F, Im W (2022) Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern. https:\/\/doi.org\/10.1101\/2022.01.24.477633. bioRxiv.","DOI":"10.1101\/2022.01.24.477633"},{"key":"10048_CR5","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"L Shrestha","year":"2022","unstructured":"Shrestha L, Foster C, Rawlinson W, Tedla N, Bull R (2022) Evolution of the SARS-CoV-2omicron variants BA.1 to BA.5: implications for immune escape and transmission. Rev Med Virol 32:e2381. https:\/\/doi.org\/10.1002\/rmv.2381","journal-title":"Rev Med Virol"},{"key":"10048_CR6","unstructured":"WHO, Tracking, SARS-CoV-2 Variants (2022). Available online at: https:\/\/www.who.int\/activities\/tracking-SARSCoV-2-variants (accessed 4 February, 2023)"},{"key":"10048_CR7","doi-asserted-by":"publisher","unstructured":"Singh P, Sharma K, Shaw D, Bhargava A, Negi SS (2023) Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India. Front Med 9. https:\/\/doi.org\/10.3389\/fmed.2022.1082846","DOI":"10.3389\/fmed.2022.1082846"},{"key":"10048_CR8","doi-asserted-by":"publisher","first-page":"106698","DOI":"10.1016\/j.ijsu.2022.106698","volume":"103","author":"R Mohapatra","year":"2022","unstructured":"Mohapatra R, Kandi V, Sarangi A, Verma S, Tuli H, Chakraborty S et al (2022) The recently emerged BA.4 and BA.5 lineages of omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic\u2013correspondence. Int J Surg 103:106698. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106698","journal-title":"Int J Surg"},{"key":"10048_CR9","unstructured":"Tracked lineages in India- available at https:\/\/outbreak.info\/location-reports (accessed on 22.09.2024)"},{"key":"10048_CR10","unstructured":"Illumina COVIDSeq RUO Kits. Reference Guide 1000000126053 v08. Illumina (2022) https:\/\/support.illumina.com\/content\/dam\/illumina-support\/documents\/documentation\/chemistry_documentation\/Illumina-COVIDSeq-Test\/illumina-covidseq-ruo-kits-reference-guide-1000000126053-08.pdf. Accessed on 07.10.2023"},{"key":"10048_CR11","unstructured":"MiSeq System. Denature and Dilute Libraries Guide. Document # 15039740 v10. Illumina (2019) https:\/\/support.illumina.com\/content\/dam\/illumina-support\/documents\/documentation\/system_documentation\/miseq\/miseq-denature-dilute-libraries-guide-15039740-10.pdf. Accessed on 07.10.2023"},{"key":"10048_CR12","unstructured":"MiSeq System Guide. Document # 15027617 v05 Material # 20000262. Illumina (2019) https:\/\/support.illumina.com\/content\/dam\/illumina-support\/documents\/documentation\/system_documentation\/miseq\/miseq-system-guide-for-local-run-manager-15027617-05.pdf. Accessed on 07.10.2023"},{"key":"10048_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41588-021-00862-7","volume":"53","author":"Y Turakhia","year":"2021","unstructured":"Turakhia Y, Thornlow B, Hinrichs AS et al (2021) Ultrafast Sample placement on existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat Genet 53:809\u2013816. https:\/\/doi.org\/10.1038\/s41588-021-00862-7","journal-title":"Nat Genet"},{"key":"10048_CR14","doi-asserted-by":"publisher","unstructured":"Singh UB, Deb S, Rani L, Bhardwaj D, Gupta R, Kabra M et al (2023) Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76. Lancet Reg Health Southeast Asia 100148. https:\/\/doi.org\/10.1016\/j.lansea.2023.100148","DOI":"10.1016\/j.lansea.2023.100148"},{"issue":"3","key":"10048_CR15","doi-asserted-by":"publisher","first-page":"100755","DOI":"10.1016\/j.xpro.2021.100755","volume":"2","author":"RC Bhoyar","year":"2021","unstructured":"Bhoyar RC, Senthivel V, Jolly B et al (2021) An optimized, Amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms. STAR Protoc 2(3):100755. https:\/\/doi.org\/10.1016\/j.xpro.2021.100755","journal-title":"STAR Protoc"},{"key":"10048_CR16","doi-asserted-by":"publisher","first-page":"955930","DOI":"10.3389\/fmed.2022.955930","volume":"9","author":"K Zaman","year":"2022","unstructured":"Zaman K, Shete AM, Mishra SK, Kumar A, Reddy MM, Sahay RR et al (2022) Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India. Front Med (Lausanne) 9:955930. https:\/\/doi.org\/10.3389\/fmed.2022.955930","journal-title":"Front Med (Lausanne)"},{"key":"10048_CR17","doi-asserted-by":"publisher","first-page":"1082846","DOI":"10.3389\/fmed.2022.1082846","volume":"9","author":"P Singh","year":"2023","unstructured":"Singh P, Sharma K, Shaw D, Bhargava A, Negi SS (2023) Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India. Front Med (Lausanne) 9:1082846. https:\/\/doi.org\/10.3389\/fmed.2022.1082846","journal-title":"Front Med (Lausanne)"},{"key":"10048_CR18","doi-asserted-by":"publisher","first-page":"109882","DOI":"10.1016\/j.virol.2023.109882","volume":"587","author":"SZ Afrin","year":"2023","unstructured":"Afrin SZ, Sathi FA, Nooruzzaman M, Parvin R (2023) Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution. Virology 587:109882. https:\/\/doi.org\/10.1016\/j.virol.2023.109882","journal-title":"Virology"},{"key":"10048_CR19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ijbiomac.2022.07.254","volume":"219","author":"C Chakraborty","year":"2022","unstructured":"Chakraborty C, Bhattacharya M, Sharma AR, Mallik B (2022) Omicron (B.1.1.529) - a new heavily mutated variant: mapped location and probable properties of its mutations with an emphasis on S-glycoprotein. Int J Biol Macromol 219:980\u2013997. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.254","journal-title":"Int J Biol Macromol"},{"key":"10048_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.omtn.2023.01.013","volume":"31","author":"C Chakraborty","year":"2023","unstructured":"Chakraborty C, Saha A, Bhattacharya M, Dhama K, Agoramoorthy G (2023) Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants. Mol Ther Nucleic Acids 31:437\u2013439. https:\/\/doi.org\/10.1016\/j.omtn.2023.01.013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10048_CR21","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA (2022) Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission. Rev Med Virol 32(5):e2381. https:\/\/doi.org\/10.1002\/rmv.2381","journal-title":"Rev Med Virol"},{"issue":"1","key":"10048_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12088-023-01057-w","volume":"63","author":"KM Ha","year":"2023","unstructured":"Ha KM, Targeting the Variants of COVID-19 via the Unlimited Approach (2023) Indian J Microbiol 63(1):152\u2013154. https:\/\/doi.org\/10.1007\/s12088-023-01057-w","journal-title":"Indian J Microbiol"},{"key":"10048_CR23","unstructured":"Vaccinate India, Tripura https:\/\/vaccinate-india.in\/state\/33. Accessed on 30.04.2024"},{"issue":"4","key":"10048_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s10787-023-01253-6","volume":"31","author":"M Sabbatucci","year":"2023","unstructured":"Sabbatucci M, Vitiello A, Clemente S, Zovi A, Boccellino M, Ferrara F et al (2023) Omicron variant evolution on vaccines and monoclonal antibodies. Inflammopharmacology 31(4):1779\u20131788. https:\/\/doi.org\/10.1007\/s10787-023-01253-6","journal-title":"Inflammopharmacology"},{"issue":"14","key":"10048_CR25","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","volume":"185","author":"A Tuekprakhon","year":"2022","unstructured":"Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A et al (2022) Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell 185(14):2422\u20132433e13. https:\/\/doi.org\/10.1016\/j.cell.2022.06.005","journal-title":"Cell"},{"issue":"1","key":"10048_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s42003-023-04923-x","volume":"6","author":"SB Park","year":"2023","unstructured":"Park SB, Khan M, Chiliveri SC, Hu X, Irvin P, Leek M et al (2023) SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Commun Biol 6(1):556. https:\/\/doi.org\/10.1038\/s42003-023-04923-x","journal-title":"Commun Biol"},{"issue":"13","key":"10048_CR27","doi-asserted-by":"publisher","first-page":"e2300360120","DOI":"10.1073\/pnas.2300360120","volume":"120","author":"K Yang","year":"2023","unstructured":"Yang K, Wang C, Kreutzberger AJB, White KI, Pfuetzner RA, Esquivies L et al (2023) Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor. Proc Natl Acad Sci U S A 120(13):e2300360120. https:\/\/doi.org\/10.1073\/pnas.2300360120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10048_CR28","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","volume":"30","author":"A Saito","year":"2022","unstructured":"Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Anraku Y et al (2022) Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe 30(11):1540\u20131555e15. https:\/\/doi.org\/10.1016\/j.chom.2022.10.003","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10048_CR29","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.chom.2022.09.018","volume":"30","author":"Y Cao","year":"2022","unstructured":"Cao Y, Song W, Wang L, Liu P, Yue C, Jian F et al (2022) Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe 30(11):1527\u20131539e5. https:\/\/doi.org\/10.1016\/j.chom.2022.09.018","journal-title":"Cell Host Microbe"},{"issue":"18","key":"10048_CR30","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.26355\/eurrev_202109_26805","volume":"25","author":"M Wahid","year":"2021","unstructured":"Wahid M, Jawed A, Mandal RK, Dailah HG, Janahi EM, Dhama K et al (2021) Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies. Eur Rev Med Pharmacol Sci 25(18):5857\u20135864. https:\/\/doi.org\/10.26355\/eurrev_202109_26805","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10048_CR31","doi-asserted-by":"publisher","first-page":"100148","DOI":"10.1016\/j.lansea.2023.100148","volume":"11","author":"UB Singh","year":"2023","unstructured":"Singh UB, Deb S, Rani L, Bhardwaj D, Gupta R, Kabra M et al (2023) Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76. Lancet Reg Health Southeast Asia 11:100148. https:\/\/doi.org\/10.1016\/j.lansea.2023.100148","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10048_CR32","doi-asserted-by":"publisher","first-page":"100272","DOI":"10.1016\/j.lansea.2023.100272","volume":"19","author":"ST Selvavinayagam","year":"2023","unstructured":"Selvavinayagam ST, Karishma SJ, Hemashree K, Yong YK, Suvaithenamudhan S, Rajeshkumar M et al (2023) Clinical characteristics and novel mutations of omicron subvariant XBB in Tamil Nadu, India - a cohort study. Lancet Reg Health Southeast Asia 19:100272. https:\/\/doi.org\/10.1016\/j.lansea.2023.100272","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"1","key":"10048_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.22207\/JPAM.18.1.57","volume":"18","author":"S Pal","year":"2024","unstructured":"Pal S, Rana G, Singhal S, Singh M, Kumar M, Thaledi S et al (2024) Characterization and distribution of Sars-CoV-2 Omicron variant and its sub-lineages in Uttarakhand using Next Generation sequencing: a retrospective study. J Pure Appl Microbiol 18(1):682\u2013695. https:\/\/doi.org\/10.22207\/JPAM.18.1.57","journal-title":"J Pure Appl Microbiol"},{"issue":"1","key":"10048_CR34","doi-asserted-by":"publisher","first-page":"17476","DOI":"10.1038\/s41598-024-68678-z","volume":"14","author":"ST Selvavinayagam","year":"2024","unstructured":"Selvavinayagam ST, Sankar S, Yong YK, Murugesan A, Suvaithenamudhan S, Hemashree K et al (2024) Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations. Sci Rep 14(1):17476. https:\/\/doi.org\/10.1038\/s41598-024-68678-z","journal-title":"Sci Rep"},{"issue":"10","key":"10048_CR35","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.30367","volume":"236","author":"A Khan","year":"2021","unstructured":"Khan A, Zia T, Suleman M et al (2021) Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: an insight from structural data. J Cell Physiol 236(10):7045\u20137057. https:\/\/doi.org\/10.1002\/jcp.30367","journal-title":"J Cell Physiol"},{"issue":"7","key":"10048_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B et al (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19(7):409\u2013424. https:\/\/doi.org\/10.1038\/s41579-021-00573-0","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10048_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41421-023-00575-7","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang Y, Pan X, Ji H, Zuo X, Xiao GF, Li J et al (2023) Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB. Cell Discov 9(1):80. https:\/\/doi.org\/10.1038\/s41421-023-00575-7","journal-title":"Cell Discov"},{"key":"10048_CR38","doi-asserted-by":"publisher","unstructured":"Alsuwairi FA, Alsaleh AN, Alsanea MS, Al-Qahtani AA, Obeid D, Almaghrabi RS et al (2023) Association of SARS-CoV-2 Nucleocapsid Protein Mutations with Patient Demographic and Clinical Characteristics during the Delta and Omicron Waves. Microorganisms;11(5):1288. https:\/\/doi.org\/10.3390\/microorganisms11051288","DOI":"10.3390\/microorganisms11051288"},{"key":"10048_CR39","doi-asserted-by":"publisher","unstructured":"Wu JL, Kuan II, Guo JY, Hsu WC, Tang WC, Chan HJ et al (2023) SARS-CoV-2\u00a0N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron. iScience;26(2):105995. https:\/\/doi.org\/10.1016\/j.isci.2023.105995","DOI":"10.1016\/j.isci.2023.105995"},{"key":"10048_CR40","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.12.142","volume":"170","author":"M Bianchi","year":"2021","unstructured":"Bianchi M, Borsetti A, Ciccozzi M, Pascarella S (2021) SARS-Cov-2 ORF3a: mutability and function. Int J Biol Macromol 170:820\u2013826. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.142","journal-title":"Int J Biol Macromol"},{"key":"10048_CR41","doi-asserted-by":"publisher","unstructured":"Kehrer T, Cupic A, Ye C, Yildiz S, Bouhaddou M, Crossland NA et al (2023) Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Cell Host Microbe. 2023;31(10):1668\u20131684.e12. https:\/\/doi.org\/10.1016\/j.chom.2023.08.003","DOI":"10.1016\/j.chom.2023.08.003"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10048-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10048-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:42:25Z","timestamp":1738730545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10048-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10048"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10048-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was an observational cross sectional study approved by Institutional Ethics committee of AGMC & GBP Hospital (ECR\/937\/Inst\/TR 2017, dated 08\/05\/2019 and F.4(5-244)\/AGMC\/Academic\/IEC Certificate\/2021\/17553, dated 26.11.2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"As the study involved samples received as part of routine diagnostic process during pandemic period with lockdown in effect, it was not possible to obtain informed consent from all the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1100"}}